Bilal Al‐Sarireh

3.0k total citations
21 papers, 250 citations indexed

About

Bilal Al‐Sarireh is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bilal Al‐Sarireh has authored 21 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bilal Al‐Sarireh's work include Pancreatic and Hepatic Oncology Research (12 papers), Pancreatitis Pathology and Treatment (9 papers) and Gallbladder and Bile Duct Disorders (5 papers). Bilal Al‐Sarireh is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), Pancreatitis Pathology and Treatment (9 papers) and Gallbladder and Bile Duct Disorders (5 papers). Bilal Al‐Sarireh collaborates with scholars based in United Kingdom, Australia and China. Bilal Al‐Sarireh's co-authors include Nicholas Mowbray, Guy Shingler, David Griffith, William J. Griffiths, Tim Brown, Gareth Jenkins, Yuqin Wang, Peter J. Crick, Paula Ghaneh and M Hartley and has published in prestigious journals such as British Journal of Cancer, British journal of surgery and Surgical Endoscopy.

In The Last Decade

Bilal Al‐Sarireh

20 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bilal Al‐Sarireh United Kingdom 9 177 130 96 38 24 21 250
Hyung Jun Kwon South Korea 8 117 0.7× 144 1.1× 95 1.0× 26 0.7× 21 0.9× 33 248
Hajime Ushigome Japan 10 113 0.6× 106 0.8× 94 1.0× 35 0.9× 25 1.0× 30 225
Shaesta Mehta India 10 163 0.9× 199 1.5× 159 1.7× 22 0.6× 24 1.0× 28 319
Mehmet Akif Türkoğlu Türkiye 10 124 0.7× 200 1.5× 73 0.8× 65 1.7× 11 0.5× 23 312
Fatih Saygılı Türkiye 9 104 0.6× 123 0.9× 53 0.6× 18 0.5× 30 1.3× 18 286
Berkant Sönmez Türkiye 7 82 0.5× 87 0.7× 63 0.7× 28 0.7× 19 0.8× 10 237
Luca Pompella Italy 9 164 0.9× 106 0.8× 125 1.3× 60 1.6× 37 1.5× 25 302
Vikas Ostwal India 9 158 0.9× 81 0.6× 58 0.6× 24 0.6× 15 0.6× 63 273
Jae Young Kwak South Korea 10 217 1.2× 217 1.7× 51 0.5× 28 0.7× 41 1.7× 19 332
Akinori Maruta Japan 10 150 0.8× 168 1.3× 124 1.3× 55 1.4× 19 0.8× 37 281

Countries citing papers authored by Bilal Al‐Sarireh

Since Specialization
Citations

This map shows the geographic impact of Bilal Al‐Sarireh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bilal Al‐Sarireh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bilal Al‐Sarireh more than expected).

Fields of papers citing papers by Bilal Al‐Sarireh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bilal Al‐Sarireh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bilal Al‐Sarireh. The network helps show where Bilal Al‐Sarireh may publish in the future.

Co-authorship network of co-authors of Bilal Al‐Sarireh

This figure shows the co-authorship network connecting the top 25 collaborators of Bilal Al‐Sarireh. A scholar is included among the top collaborators of Bilal Al‐Sarireh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bilal Al‐Sarireh. Bilal Al‐Sarireh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haboubi, Hasan, et al.. (2023). Measuring blood cell DNA damage using the PIG-A mutation and CBMN assay in pancreatic cancer patients: a pilot study. Mutagenesis. 38(2). 93–99. 2 indexed citations
2.
Al‐Sarireh, Bilal, et al.. (2023). Frontline clinical diagnosis—FTIR on pancreatic cancer. Cancer Medicine. 12(16). 17340–17345. 5 indexed citations
3.
Pandé, Rupaly, Joseph Attard, Bilal Al‐Sarireh, et al.. (2023). Oncological outcomes after pancreatoduodenectomy for pancreatic ductal adenocarcinoma in octogenarians: case-control study. BJS Open. 7(4). 4 indexed citations
4.
Shingler, Guy, et al.. (2021). The Burden of Pancreatic Cystic Neoplasms on a Regional MDT. HPB. 23. S899–S899.
5.
Attard, Joseph, Bilal Al‐Sarireh, Ricky H. Bhogal, et al.. (2021). Short-term outcomes after pancreatoduodenectomy in octogenarians: multicentre case–control study. British journal of surgery. 109(1). 89–95. 6 indexed citations
6.
Sun, Zhiwei, Ping‐Hui Sun, Xiangyu Gao, et al.. (2021). Reduced kinase D‑interacting substrate of 220 kDa (Kidins220) in pancreatic cancer promotes EGFR/ERK signalling and disease progression. International Journal of Oncology. 58(6). 4 indexed citations
7.
Moekotte, Alma, Sanne Lof, Ravi Marudanayagam, et al.. (2020). Splenic preservation versus splenectomy in laparoscopic distal pancreatectomy: A propensity score matched study. HPB. 22. S402–S402. 1 indexed citations
8.
Moekotte, Alma, Sanne Lof, Steve White, et al.. (2019). Splenic preservation versus splenectomy in laparoscopic distal pancreatectomy: a propensity score-matched study. Surgical Endoscopy. 34(3). 1301–1309. 15 indexed citations
9.
Al‐Sarireh, Bilal, et al.. (2018). Can infected pancreatic necrosis really be managed conservatively?. European Journal of Gastroenterology & Hepatology. 30(11). 1327–1331. 8 indexed citations
10.
Al‐Sarireh, Bilal, et al.. (2018). Ruptured pseudoaneurysm of an unnamed vessel as complication of chronic pancreatitis. Journal of Surgical Case Reports. 2018(8). rjy194–rjy194. 2 indexed citations
11.
12.
Mowbray, Nicholas, et al.. (2018). The microbiology of infected pancreatic necrosis. Hepatobiliary & pancreatic diseases international. 17(5). 456–460. 29 indexed citations
13.
Hughes, Daniel, et al.. (2018). Intraductal papillary mucinous neoplasm's 100 most significant manuscripts: A bibliometric analysis. Research Explorer (The University of Manchester). 8(1). 1–11. 3 indexed citations
14.
Crick, Peter J., Gareth Jenkins, Yuqin Wang, et al.. (2017). Comparison of the composition of bile acids in bile of patients with adenocarcinoma of the pancreas and benign disease. The Journal of Steroid Biochemistry and Molecular Biology. 174. 290–295. 38 indexed citations
15.
Shingler, Guy, Nicholas Mowbray, Bilal Al‐Sarireh, et al.. (2017). Surgical outcomes for duodenal adenoma and adenocarcinoma: a multicentre study in Australia and the United Kingdom. ANZ Journal of Surgery. 88(3). E157–E161. 16 indexed citations
16.
Liu, Ying, Ping‐Hui Sun, Gang Chen, et al.. (2017). Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression. International Journal of Oncology. 50(5). 1491–1500. 13 indexed citations
17.
Mowbray, Nicholas, et al.. (2016). Laparoscopic Left Pancreatectomy in the United Kingdom. Pancreas. 45(8). 1204–1207. 2 indexed citations
18.
Yadegarfar, Ghasem, Elizabeth Friend, Christopher O’Donnell, et al.. (2016). Validation of the EORTC QLQ-BIL21 questionnaire for measuring quality of life in patients with cholangiocarcinoma and cancer of the gallbladder. British Journal of Cancer. 115(9). 1032–1038. 26 indexed citations
19.
Pilgrim, Charles, Peter Evans, Malcolm A. Smith, et al.. (2016). Surgical outcomes for duodenal adenoma and adenocarcinoma: A multicentre study in Australia and the United Kingdom. HPB. 18. e360–e360. 6 indexed citations
20.
Stocks, Percy, et al.. (2005). CASE OF THE CONFERENCE: PRIMARY SQUAMOUS CELL CARCINOMA IN A LONG BONE.. 6–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026